Zdrowie i gospodarka · 20/07/2017
FDA to Host Public Meeting on Patient-Focused Drug Development for Hereditary Angioedema
The FDA is seeking public input on patient-focused drug development for hereditary angioedema, as part of its commitment to improve treatment options for patients with this condition.
Source: Federal Register — Food and Drug AdministrationOpen original release →